An official website of the United States governmentFor the Media
The NCCIH Press Office provides members of the media with accurate, up-to-date information regarding complementary and integrative health approaches as well as research funded and conducted by NCCIH. Contact us if you need information that you haven't found on our website, if you wish to request an interview with a subject matter expert, or if you need other assistance. We will work with you to respond to your request and meet your deadline.
How to Reach Us
Phone: 301-496-7790
Email: nccihpress@mail.nih.gov (for media inquiries only)
Hours of Operation: 8:30 a.m. to 4:30 p.m. ET, Monday through Friday.
Closed: Federal holidays
We will respond the next business day to telephone calls or emails received after hours.
If you are not a member of the media and have an inquiry, contact NCCIH's Clearinghouse by toll-free in the United States at 1-888-644-6226; or email at nccih-info@mail.nih.gov.
Contacting Other NIH Media Offices
- List of phone numbers for media contacts at all NIH Institutes and Centers www.nih.gov/news/media_contacts.htm
- Links to the News sections of all NIH Institutes and Center's Web sites www.nih.gov/news/moresources.htm
- Other HHS media offices:
https://www.hhs.gov/about/news/contacts/index.html
Press Releases
Recent Research Results
Telehealth Mindfulness-Based Interventions Were Helpful for Veterans With Chronic Pain in a Large Real-World Study
In a study of veterans with moderate-to-severe chronic pain, 8-week virtual group or self-paced mindfulness-based interventions were more helpful than usual care in improving pain-related function. This study, which was part of the Pain Management Collaboratory (PMC), a large-scale effort to assess nondrug treatments for pain in the military and veterans’ health care systems, was supported by the PMC Coordinating Center, which is funded by the National Center for Complementary and Integrative Health and published in the journal JAMA Internal Medicine.
August 2024
In a Large Multicenter Trial, Chelation Therapy Did Not Reduce Cardiovascular Disease Events in Patients With Diabetes and a History of Heart Attack
Chelation therapy does not reduce the occurrence of major adverse cardiovascular events in patients with diabetes who have had a myocardial infarction even though it effectively reduces blood lead levels, according to a multicenter clinical trial funded by the National Institutes of Health (NIH). The results, which did not replicate those of an earlier trial, were published in the Journal of the American Medical Association.
August 2024
- Search NCCIH-Funded Research Studies (PubMed)
- Search RePORTER (NIH)—an electronic tool that allows users to search a repository of NIH-funded research projects and access publications and patents resulting from NIH funding.